Robert Flamini

3.3k total citations · 1 hit paper
21 papers, 957 citations indexed

About

Robert Flamini is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert Flamini has authored 21 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 11 papers in Pediatrics, Perinatology and Child Health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert Flamini's work include Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Neuroscience and Neuropharmacology Research (5 papers). Robert Flamini is often cited by papers focused on Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Neuroscience and Neuropharmacology Research (5 papers). Robert Flamini collaborates with scholars based in United States, United Kingdom and Italy. Robert Flamini's co-authors include Linda Laux, Elizabeth A. Thiele, Orrin Devinsky, Ian Miller, Anup D. Patel, Angus A. Wilfong, Beth A. Malow, Jerzy P. Szaflarski, Laurie E. Seltzer and E. Martina Bebin and has published in prestigious journals such as Neurology, Epilepsia and Headache The Journal of Head and Face Pain.

In The Last Decade

Robert Flamini

19 papers receiving 909 citations

Hit Papers

Randomized, dose-ranging safety trial of cannabidiol in D... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
    2018 340 citations Orrin Devinsky, Anup D. Patel et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Flamini United States 12 584 496 323 310 83 21 957
Claire Roberts United Kingdom 8 596 1.0× 731 1.5× 369 1.1× 224 0.7× 136 1.6× 17 1.2k
Patricia L. Bruno United States 10 469 0.8× 491 1.0× 275 0.9× 192 0.6× 124 1.5× 14 884
Alexandra L. Geffrey United States 7 381 0.7× 438 0.9× 227 0.7× 144 0.5× 109 1.3× 12 718
Gilmour Morrison United Kingdom 10 436 0.7× 1.0k 2.1× 297 0.9× 184 0.6× 96 1.2× 16 1.2k
Robert Wechsler United States 18 1.0k 1.8× 276 0.6× 729 2.3× 758 2.4× 108 1.3× 45 1.3k
Daniel Checketts United Kingdom 17 922 1.6× 1.2k 2.4× 560 1.7× 369 1.2× 172 2.1× 29 1.7k
Amitabh Dash Japan 12 342 0.6× 123 0.2× 151 0.5× 204 0.7× 56 0.7× 31 673
Juan A. Armijo Spain 18 647 1.1× 68 0.1× 236 0.7× 631 2.0× 30 0.4× 53 971
Lennart Gram Denmark 21 1.1k 1.9× 57 0.1× 467 1.4× 963 3.1× 74 0.9× 37 1.4k
José H. Woodhead United States 14 566 1.0× 100 0.2× 533 1.7× 351 1.1× 38 0.5× 19 982

Countries citing papers authored by Robert Flamini

Since Specialization
Citations

This map shows the geographic impact of Robert Flamini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Flamini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Flamini more than expected).

Fields of papers citing papers by Robert Flamini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Flamini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Flamini. The network helps show where Robert Flamini may publish in the future.

Co-authorship network of co-authors of Robert Flamini

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Flamini. A scholar is included among the top collaborators of Robert Flamini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Flamini. Robert Flamini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Flamini, Robert, Andrea Rossi, Enrico Bertini, et al.. (2024). Stress and Quality of Life of Parents of Children With POLR3-Related Leukodystrophy: A Cross-Sectional Pilot Study. Journal of Child Neurology. 40(1). 26–38.
3.
Sullivan, Joseph, Elaine Wirrell, Kelly G. Knupp, et al.. (2024). Adaptive functioning and neurodevelopment in patients with Dravet syndrome: 12-month interim analysis of the BUTTERFLY observational study. Epilepsy & Behavior. 151. 109604–109604. 10 indexed citations
4.
Flamini, Robert, Anne M. Comi, E. Martina Bebin, et al.. (2023). Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment‐resistant epilepsies in the Expanded Access Program. Epilepsia. 64(8). e156–e163. 13 indexed citations
5.
Bayat, Allan, Francesco Miceli, Katrine M. Johannesen, et al.. (2023). Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment. Neurotherapeutics. 21(1). e00296–e00296. 5 indexed citations
6.
Sullivan, Joseph, Elaine Wirrell, Kelly G. Knupp, et al.. (2022). Interim results of adaptive functioning and neurodevelopment in BUTTERFLY – An observational study of children and adolescents with Dravet syndrome. Epilepsy & Behavior. 137(Pt A). 108955–108955. 5 indexed citations
7.
8.
9.
10.
Laux, Linda, E. Martina Bebin, Daniel Checketts, et al.. (2019). Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy Research. 154. 13–20. 143 indexed citations
11.
Devinsky, Orrin, Chloe Verducci, Elizabeth A. Thiele, et al.. (2018). Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes. Epilepsy & Behavior. 86. 131–137. 136 indexed citations
12.
Devinsky, Orrin, Anup D. Patel, Elizabeth A. Thiele, et al.. (2018). Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology. 90(14). e1204–e1211. 340 indexed citations breakdown →
13.
Aguilera, Dolly, Robert Flamini, Claire Mazewski, et al.. (2013). Response of Subependymal Giant Cell Astrocytoma With Spinal Cord Metastasis to Everolimus. Journal of Pediatric Hematology/Oncology. 36(7). e448–e451. 9 indexed citations
14.
Jóźwiak, Sergiusz, Е. Д. Белоусова, Christopher Kingswood, et al.. (2012). 74 The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma. European Urology Supplements. 11(1). e74–e74a. 3 indexed citations
15.
Resnick, Trevor, Alexis Arzimanoglou, Lawrence W. Brown, et al.. (2011). Rufinamide from clinical trials to clinical practice in the United States and Europe. Epileptic Disorders. 13(S1). S27–43. 12 indexed citations
16.
Siegel, Heidi E., Kathleen Kelley, Patricia Reeves‐Tyer, et al.. (1999). The efficacy of felbamate as add-on therapy to valproic acid in the Lennox–Gastaut syndrome. Epilepsy Research. 34(2-3). 91–97. 39 indexed citations
17.
Ketter, T A, Beth A. Malow, Robert Flamini, et al.. (1996). Felbamate monotherapy has stimulant-like effects in patients with epilepsy. Epilepsy Research. 23(2). 129–137. 40 indexed citations
18.
Theodore, William H., Paul Albert, Beth A. Malow, et al.. (1995). Felbamate Monotherapy: Implications for Antiepileptic Drug Development. Epilepsia. 36(11). 1105–1110. 31 indexed citations
19.
Gaillard, William D., Silke White, Beth A. Malow, et al.. (1995). FDG-PET in children and adolescents with partial seizures: Role in epilepsy surgery,evaluation. Epilepsy Research. 20(1). 77–84. 50 indexed citations
20.
Ketter, T A, Beth A. Malow, Robert Flamini, et al.. (1994). Anticonvulsant withdrawal‐emergent psychopathology. Neurology. 44(1). 55–55. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Roberts Breakdown of academic impact, for papers by Patricia L. Bruno Breakdown of academic impact, for papers by Alexandra L. Geffrey Breakdown of academic impact, for papers by Gilmour Morrison Breakdown of academic impact, for papers by Robert Wechsler Breakdown of academic impact, for papers by Daniel Checketts Breakdown of academic impact, for papers by Amitabh Dash Breakdown of academic impact, for papers by Juan A. Armijo Breakdown of academic impact, for papers by Lennart Gram Breakdown of academic impact, for papers by José H. Woodhead
Rankless by CCL
2026